RESEARCH TRIANGLE PARK, N.C. - October 2, 2002 - Quintiles Transnational Corp. (Nasdaq: QTRN) announced today that Ray Dawkins, M.D., has joined its North American Clinical Development Services unit as Director, Medical & Scientific Services.
In his new position, Dawkins will provide medical consultation and therapeutic expertise as a key member of the company's Clinical Development Services project teams.
"Ray brings to our group a broad-based knowledge of the pharmaceutical industry in cardiovascular medicine, gastrointestinal disorders and anti-infectives," said David Frakes, M.D., Vice President, Medical & Scientific Services. "He adds further depth and breadth to the experience of our North American Medical & Scientific Services team, which already has 18 physicians with a total of more than 350 years of post-graduate medical and scientific research experience and board certification in 16 distinct subspecialty areas of medicine."
Dawkins joins Quintiles with an extensive background in drug development. Most recently, he served as the principal investigator for all studies conducted at PPD Development's Phase I clinic in Research Triangle Park. Earlier, he served as international director for the ACE inhibitor quinapril in the cardiovascular group of Parke-Davis in Ann Arbor, Michigan. At Parke-Davis, Dawkins was responsible for conducting Phase IIIb and IV studies on quinapril worldwide. Prior to that, Dawkins served as the medical director of Clinical Research International, a contract research organization based in Research Triangle Park. He also has served as the assistant director of Clinical Development at Glaxo, Inc., where he was responsible for Phase IV trials, publications and marketing interactions for the gastrointestinal and anti-infectives groups.
Dawkins received his medical degree from Duke University School of Medicine in Durham, N.C. He completed a residency in internal medicine at the University of Missouri Health Sciences Center, Columbia, Mo., and spent 13 years in private practice in internal medicine.
Quintiles Transnational helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Headquartered near Research Triangle Park, North Carolina, Quintiles is a member of the S&P 500 and Fortune 1000. For more information visit the company's Web site at www.quintiles.com.